Akeso, Inc.: Chinese biopharma developing antibody-based cancer immunotherapies.
| Exchange | Symbol | Mark | Index | Basis | FundingEach venue's rate is converted to an hourly equivalent. Annualized funding = hourly rate × 24 × 365 (not compounded). Multi-venue values are weighted by 24h volume. | Volume 24h | Vol % | OI (USD) | Live |
|---|---|---|---|---|---|---|---|---|---|
![]() | AKESO_USDT | 12.17 | 12.21 | -32.4 bps | +0.00% +0.0000% / 8h · -- | $8.32K | 100.0% | $24.78K | 167d |